Sign up for our Newsletter
The Pancreatic Cancer Action Network will award $4.1 million in research funding through its 2015 Grants Program. Applications are now being accepted for most grants.
Now published in Cancer Research: a Pancreatic Cancer Action Network study predicting that pancreatic cancer will be the second leading cause of cancer-related death around 2020. Learn more.
MM-398 combined with standard chemotherapy boosts overall survival by nearly 2 months in patients previously treated with gemcitabine. Learn more.